Literature DB >> 32467653

Improving Developmental Abilities in Infants With Tuberous Sclerosis Complex: A Pilot Behavioral Intervention Study.

Nicole M McDonald1, Carly Hyde1, April Boin Choi1, Amanda C Gulsrud1, Connie Kasari1, Charles A Nelson1, Shafali S Jeste1.   

Abstract

Tuberous sclerosis complex (TSC) is a rare genetic syndrome that confers risk for neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. Delays in social communication and early cognitive abilities are observable as early as 9 months of age in children with TSC; however, there have been no studies of early behavioral intervention in TSC. We conducted a pilot study of an evidence-based, parent-mediated behavioral intervention focused on improving early social communication and play skills in 5 children with TSC (aged 1-3 years). Participants showed maintenance and sometimes gains in developmental abilities, relative to peers, following intervention. Parents generally found the intervention to be helpful and were able to administer the intervention with fidelity. Preliminary results demonstrate initial feasibility of an early play-based, parent-mediated intervention and support the need for a large-scale, randomized clinical trial in TSC.

Entities:  

Keywords:  autism spectrum disorder; behavioral intervention; early intervention; tuberous sclerosis complex

Year:  2020        PMID: 32467653      PMCID: PMC7255424          DOI: 10.1097/iyc.0000000000000160

Source DB:  PubMed          Journal:  Infants Young Child        ISSN: 0896-3746


  2 in total

1.  Future Directions for Infant Identification and Intervention for Autism Spectrum Disorder from a Transdiagnostic Perspective.

Authors:  Meagan R Talbott; Meghan R Miller
Journal:  J Clin Child Adolesc Psychol       Date:  2020-07-23

Review 2.  The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.

Authors:  Stephanie Vanclooster; Stacey Bissell; Agnies M van Eeghen; Nola Chambers; Liesbeth De Waele; Anna W Byars; Jamie K Capal; Sebastián Cukier; Peter Davis; Jennifer Flinn; Sugnet Gardner-Lubbe; Tanjala Gipson; Tosca-Marie Heunis; Dena Hook; J Christopher Kingswood; Darcy A Krueger; Aubrey J Kumm; Mustafa Sahin; Eva Schoeters; Catherine Smith; Shoba Srivastava; Megumi Takei; Robert Waltereit; Anna C Jansen; Petrus J de Vries
Journal:  J Neurodev Disord       Date:  2022-02-13       Impact factor: 4.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.